Randamized phase II trial of S-1+CDDP vs S-1+Docetaxel for advanced and/or recurrent gastric cancer.

Trial Profile

Randamized phase II trial of S-1+CDDP vs S-1+Docetaxel for advanced and/or recurrent gastric cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 25 Jun 2015

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Docetaxel
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jun 2015 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
    • 23 Jun 2012 Planned end date changed from 1 Jun 2013 to 1 Feb 2014 as reported by University Hospital Medical Information Network - Japan.
    • 20 Jul 2011 Actual initiation date (Jul 2010) as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top